Tysabri every eight weeks may cut PML risk
Tysabri every eight weeks may cut PML risk
Preliminary findings from an ongoing study of multiple sclerosis patients suggest the dosing interval for Tysabri can be as much as doubled from the label-recommended standard without sacrificing efficacy, and with potentially less risk of progressive multifocal leukoencephalopathy (PML) -- even among patients with more than average PML risk, researchers claim... Read More - http://www.ms-uk.org/MSnews
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 2530 Views
-
Last post by NHE
-
- 6 Replies
- 7237 Views
-
Last post by ElliotB
-
- 0 Replies
- 1413 Views
-
Last post by NHE
-
- 0 Replies
- 3746 Views
-
Last post by NHE
-
- 1 Replies
- 1142 Views
-
Last post by NHE
-
- 1 Replies
- 1691 Views
-
Last post by NHE
-
- 11 Replies
- 3524 Views
-
Last post by NHE
-
- 0 Replies
- 3452 Views
-
Last post by NHE
-
- 0 Replies
- 1602 Views
-
Last post by NHE